LA DEMENZA VASCOLARE SOTTOCORTICALE ... - Carbone Editore

52 G. Zelante, A. Catalano et Al
72) Wahlund LO, Barkhof F, Fazekas F, et al. A new rating
scale for age-related white matter changes applicable
to MRI and CT. Stroke 2001; 32: 1318-22.
73) Birkenhager WH, Forette F, Seux ML, et al. Blood
pressure, cognitive functions, and prevention of dementias
in older patients with hypertension. Arch Intern
Med 2001; 161: 152-56.
74) Jick H, Zornberg GL, Jick SS, Seshadri S, et al. Statins
and the risk of dementia. Lancet 2000; 356: 1627-31.
75) Orgogozo JM, Rigaud A-S, Stoffler A, Mobius H-J,
Forette F. Efficacy and safety of memantine in patients
with mild to moderate vascular dementia: a randomized
placebo controlled trial (MMM 300). Stroke 2002;
33: 1834-39.
76) Pantoni L, Rossi R, Inzitari D, et al. Efficacy and safety
of nimodipine in subcortical vascular dementia: a subgroup
analysis of the Scandinavian Multi Infarct
Dementia Trial. J Neurol Sci 2000; 175: 124-34.
77) Moretti R, Torre P, Antonello RM, Cazzato G.
Rivastigmine in subcortical vascular dementia: a comparison
trial on efficacy and tolerability for 12 months
follow-up. Eur J Neurol 2001; 8: 361-62.
78) Erkinjuntti T, Kurtz A, Gauthier S, Bullock R,
Lillenfeld S, Damaraju CV. Efficacy of galantamine in
probable vascular dementia and Alzheimer’s disease
combined with cerebrovascular disease: a randomised
trial. Lancet 2002; 359: 1283-90.
79) Pratt R, Perdomo CA, and The Donepezil Study Group.
Results of clinical studies with donepezil in vascular
dementia. Am J Geriatr Psychiatry 2002; 10 (suppl 1):
88-89.
_________
Request reprints from:
Prof. LIBORIO RAMPELLO
Direttore U.O.C. di Neurofisiopatologia
Padiglione 2 (Neurologia)
Policlinico dell’Università di Catania
V. Santa Sofia 78
95100 Catania
(Italy)